BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36617980)

  • 21. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies.
    Baranova EE; Sagaydak OV; Galaktionova AM; Kuznetsova ES; Kaplanova MT; Makarova MV; Belenikin MS; Olenev AS; Songolova EN
    BMC Pregnancy Childbirth; 2022 Aug; 22(1):633. PubMed ID: 35945516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis.
    Torres Aguilar MR; Carrasco Salas P; Santos Rosa C; Bueno Rodríguez G; Martínez-Bonet E; Carreto Alba P; León-Justel A; Granell Escobar MR
    Taiwan J Obstet Gynecol; 2021 Jul; 60(4):745-751. PubMed ID: 34247818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audit of the first > 7500 noninvasive prenatal aneuploidy tests in a Swiss genetics center.
    Bajka A; Bajka M; Chablais F; Burkhardt T
    Arch Gynecol Obstet; 2022 May; 305(5):1185-1192. PubMed ID: 34533609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings.
    Meck JM; Kramer Dugan E; Matyakhina L; Aviram A; Trunca C; Pineda-Alvarez D; Aradhya S; Klein RT; Cherry AM
    Am J Obstet Gynecol; 2015 Aug; 213(2):214.e1-5. PubMed ID: 25843063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the practical applications of fluorescence
    Ju D; Li X; Shi Y; Ma Y; Guo L; Wang Y; Ma R; Zhong Y; Zhang Y; Xue F
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7422-7429. PubMed ID: 34289797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, Cytogenetic and Molecular Cytogenetic Outcomes of Cell-Free DNA Testing for Rare Chromosomal Anomalies.
    Basaran S; Has R; Kalelioglu IH; Sarac Sivrikoz T; Karaman B; Kirgiz M; Dehgan T; Kalayci T; Ozsait Selcuk B; Miny P; Yuksel A
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central China.
    Lu W; Huang T; Wang XR; Zhou JH; Yuan HZ; Yang Y; Huang TT; Liu DP; Liu YQ
    J Assist Reprod Genet; 2020 Dec; 37(12):3143-3150. PubMed ID: 33094428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.
    Rose NC; Barrie ES; Malinowski J; Jenkins GP; McClain MR; LaGrave D; Leung ML;
    Genet Med; 2022 Jul; 24(7):1379-1391. PubMed ID: 35608568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of sex chromosome aneuploidy in a prenatal population: 27-year longitudinal study in Northern Italy.
    Samango-Sprouse CA; Grati FR; Brooks M; Hamzik MP; Khaksari K; Gropman A; Taylor A; Malvestiti F; Grimi B; Liuti R; Milani S; Chinetti S; Trotta A; Agrati C; Repetti E; Martin KA
    Ultrasound Obstet Gynecol; 2023 Aug; 62(2):266-272. PubMed ID: 36929222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
    Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
    Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women should decide which conditions matter.
    Norton ME; Kuppermann M
    Am J Obstet Gynecol; 2016 Nov; 215(5):583-587.e1. PubMed ID: 27793311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal Genome-Wide Cell-Free DNA Screening: Three Years of Clinical Experience in a Hospital Prenatal Diagnostic Unit in Spain.
    Pedrola Vidal L; Roselló Piera M; Martín-Grau C; Rubio Moll JS; Gómez Portero R; Marcos Puig B; Cervera Zamora JV; Quiroga R; Orellana Alonso C
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Application of Cell-Free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in Iran.
    Garshasbi M; Wang Y; Hantoosh Zadeh S; Giti S; Piri S; Reza Hekmat M
    Fetal Diagn Ther; 2020; 47(3):220-227. PubMed ID: 31487708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
    Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
    Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
    Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
    Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
    Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 40. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.